Patients with type 2 diabetes patients and obesity who underwent metabolic surgery had a significantly lower incidence of microvascular complications, compared with those who received usual medical treatment, according to a study in the British Journal of Surgery. German researchers conducted a literature review of 10 studies involving 17,532 patients and found surgery also improved pre-existing diabetic nephropathy better than medical treatment.
